The Sox9 Transcription Factor Determines Glial Fate Choice in the Developing Spinal Cord

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2003 Jul 5

PMID 12842915

Citations 290

Authors

C Claus Stolt

Petra Lommes

Elisabeth Sock

Marie-Christine Chaboissier

Andreas Schedl

Michael Wegner

Affiliations

Soon will be listed here.

Abstract

The mechanism that causes neural stem cells in the central nervous system to switch from neurogenesis to gliogenesis is poorly understood. Here we analyzed spinal cord development of mice in which the transcription factor Sox9 was specifically ablated from neural stem cells by the CRE/loxP recombination system. These mice exhibit defects in the specification of oligodendrocytes and astrocytes, the two main types of glial cells in the central nervous system. Accompanying an early dramatic reduction in progenitors of the myelin-forming oligodendrocytes, there was a transient increase in motoneurons. Oligodendrocyte progenitor numbers recovered at later stages of development, probably owing to compensatory actions of the related Sox10 and Sox8, both of which overlap with Sox9 in the oligodendrocyte lineage. In agreement, compound loss of Sox9 and Sox10 led to a further decrease in oligodendrocyte progenitors. Astrocyte numbers were also severely reduced in the absence of Sox9 and did not recover at later stages of spinal cord development. Taking the common origin of motoneurons and oligodendrocytes as well as V2 interneurons and some astrocytes into account, stem cells apparently fail to switch from neurogenesis to gliogenesis in at least two domains of the ventricular zone, indicating that Sox9 is a major molecular component of the neuron-glia switch in the developing spinal cord.

Citing Articles

Enhanced insights into the genetic architecture of 3D cranial vault shape using pleiotropy-informed GWAS.

Goovaerts S, Naqvi S, Hoskens H, Herrick N, Yuan M, Shriver M Commun Biol. 2025; 8(1):439.

PMID: 40087503 DOI: 10.1038/s42003-025-07875-6.

Sox8: a multifaceted transcription factor in development and disease.

Gonzalez Alvarado M, Aprato J Biol Open. 2025; 14(2).

PMID: 39936824 PMC: 11849977. DOI: 10.1242/bio.061840.

Continuous cell type diversification throughout the embryonic and postnatal mouse visual cortex development.

Gao Y, van Velthoven C, Lee C, Thomas E, Bertagnolli D, Carey D bioRxiv. 2025; .

PMID: 39829740 PMC: 11741437. DOI: 10.1101/2024.10.02.616246.

Characterizing progenitor cells in developing and injured spinal cord: Insights from single-nucleus transcriptomics and lineage tracing.

Zhang Q, Wu X, Fan Y, Zhang H, Yin M, Xue X Proc Natl Acad Sci U S A. 2025; 122(2):e2413140122.

PMID: 39761400 PMC: 11745359. DOI: 10.1073/pnas.2413140122.

Short-range Fgf signalling patterns hindbrain progenitors to induce the neurogenesis-to-oligodendrogenesis switch.

Yeung T, Wilkinson D Development. 2024; 151(24).

PMID: 39575980 PMC: 11664172. DOI: 10.1242/dev.204256.

References

Zhou Q, Wang S, Anderson D . Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron. 2000; 25(2):331-43. DOI: 10.1016/s0896-6273(00)80898-3. View

Yamamoto Y, Henderson C . Patterns of programmed cell death in populations of developing spinal motoneurons in chicken, mouse, and rat. Dev Biol. 1999; 214(1):60-71. DOI: 10.1006/dbio.1999.9413. View

Wegner M . From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999; 27(6):1409-20. PMC: 148332. DOI: 10.1093/nar/27.6.1409. View

Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I, Wegner M . Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem. 1998; 273(26):16050-7. DOI: 10.1074/jbc.273.26.16050. View

Herbarth B, Pingault V, Bondurand N, Kuhlbrodt K, Hermans-Borgmeyer I, Puliti A . Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci U S A. 1998; 95(9):5161-5. PMC: 20231. DOI: 10.1073/pnas.95.9.5161. View

Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban P . Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999; 23(1):99-103. DOI: 10.1038/12703. View

Bi W, Deng J, Zhang Z, Behringer R, de Crombrugghe B . Sox9 is required for cartilage formation. Nat Genet. 1999; 22(1):85-9. DOI: 10.1038/8792. View

Peirano R, Goerich D, Riethmacher D, Wegner M . Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol. 2000; 20(9):3198-209. PMC: 85614. DOI: 10.1128/MCB.20.9.3198-3209.2000. View

Bowles J, Schepers G, Koopman P . Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000; 227(2):239-55. DOI: 10.1006/dbio.2000.9883. View

10.

Britsch S, Goerich D, Riethmacher D, Peirano R, Rossner M, Nave K . The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001; 15(1):66-78. PMC: 312607. DOI: 10.1101/gad.186601. View

11.

Jessell T . Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet. 2001; 1(1):20-9. DOI: 10.1038/35049541. View

12.

Bi W, Huang W, Whitworth D, Deng J, Zhang Z, Behringer R . Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A. 2001; 98(12):6698-703. PMC: 34415. DOI: 10.1073/pnas.111092198. View

13.

Pompolo S, Harley V . Localisation of the SRY-related HMG box protein, SOX9, in rodent brain. Brain Res. 2001; 906(1-2):143-8. DOI: 10.1016/s0006-8993(01)02574-4. View

14.

Sock E, Schmidt K, Bosl M, Wegner M . Idiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8. Mol Cell Biol. 2001; 21(20):6951-9. PMC: 99871. DOI: 10.1128/MCB.21.20.6951-6959.2001. View

15.

Kessaris N, Pringle N, Richardson W . Ventral neurogenesis and the neuron-glial switch. Neuron. 2001; 31(5):677-80. DOI: 10.1016/s0896-6273(01)00430-5. View

16.

Zhou Q, Choi G, Anderson D . The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron. 2001; 31(5):791-807. DOI: 10.1016/s0896-6273(01)00414-7. View

17.

Paratore C, Goerich D, Suter U, Wegner M, Sommer L . Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development. 2001; 128(20):3949-61. DOI: 10.1242/dev.128.20.3949. View

18.

Stolt C, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M . Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 2002; 16(2):165-70. PMC: 155320. DOI: 10.1101/gad.215802. View

19.

Spokony R, Aoki Y, Saint-Germain N, Magner-Fink E, Saint-Jeannet J . The transcription factor Sox9 is required for cranial neural crest development in Xenopus. Development. 2002; 129(2):421-32. DOI: 10.1242/dev.129.2.421. View

20.

Fu H, Qi Y, Tan M, Cai J, Takebayashi H, Nakafuku M . Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development. 2002; 129(3):681-93. DOI: 10.1242/dev.129.3.681. View